Penetration of etoposide into human malignant brain tumors after intravenous and oral administration Katsuzo KiyaTohru UozumiKaoru Kurisu Original Articles Pages: 339 - 342
Relations between the penetration, binding and average concentration of cytostatic drugs in human tumour spheroids Martin ErlansonErika Daniel-SzolgayJörgen Carlsson Original Articles Pages: 343 - 353
A phase I and pharmacokinetic study of 12-h infusion of flavone acetic acid Ian N. OlverLorraine K. WebsterKerrie H. Stokes Original Articles Pages: 354 - 360
Ionic rhenocene derivatives with antitumor activity P. Köpf-MaierT. Klapötke Original Articles Pages: 361 - 366
Relationship between the cellular accumulation and the cytotoxicity of S12363, a new vinca alkaloid derivative Alain PierréValérie PérezGhanem Atassi Original Articles Pages: 367 - 374
A phase I and pharmacology study of GR63178A, a water-soluble analogue of mitoquidone Diana M. EcclesJeffrey CummingsJohn F. Smyth Original Articles Pages: 375 - 378
Pharmacokinetics and toxicity of the antitumour agentN-[2-(dimethylamino)ethyl]acridine-4-carboxamide after i.v. administration in the mouse James W. PaxtonDeborah YoungEain M. Cornford Original Articles Pages: 379 - 384
Influence of glutathione administration on the disposition of free and total platinum in patients after administration of cisplatin R. LeoneM. E. FracassoA. Bernareggi Original Articles Pages: 385 - 390
Variability in the pharmacokinetics of epirubicin: a population analysis Janet R. WadeAndrew W. KelmanBrian Whiting Original Articles Pages: 391 - 395
Treatment of cancer patients with a low-density-lipoprotein delivery vehicle containing a cytotoxic drug Danuta FilipowskaTomasz FilipowskiAnthony Breeze Original Articles Pages: 396 - 400
Treatment of inoperable hepatocellular carcinoma by intra-arterial Lipiodol and 4′-epidoxorubicin W. T. LeungW. C. T. ShiuC. Metreweli Short Communication Pages: 401 - 404
Intestinal obstruction due to diffuse peritoneal fibrosis at 2 years after the successful treatment of malignant peritoneal mesothelioma with intraperitoneal mitoxantrone L. Thomas VlasveldBabs G. TaalSjoerd Rodenhuis Short Communication Pages: 405 - 408
Phase II study of ACNU as second-line treatment in small-cell lung cancer A. S. Th. PlantingT. A. W. SplinterEORTC Lung Cancer Cooperative Group Short Communication Pages: 409 - 411